File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/BF01299868
- Scopus: eid_2-s2.0-0026484749
- PMID: 1330461
- WOS: WOS:A1992JY62400018
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Systemic tumor necrosis factor-alpha production in experimental colitis
Title | Systemic tumor necrosis factor-alpha production in experimental colitis |
---|---|
Authors | |
Keywords | colitis inflammatory bowel disease intestine leukotrienes tumor necrosis factor |
Issue Date | 1992 |
Publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0163-2116 |
Citation | Digestive Diseases And Sciences, 1992, v. 37 n. 11, p. 1738-1745 How to Cite? |
Abstract | Tumor necrosis factor-alpha (TNF) is a cytokine released by mononuclear cells in response to inflammation and sepsis. Since the biological effects of TNF are consistent with the systemic and nal features of ulcerative colitis, the role of TNF was examined in a rabbit model of chronic colitis. Peripheral blood mononuclear cells were isolated, stimulated with lipopolysaccharide, and cultured supernatants assayed for TNF levels using a cytotoxic assay on mouse fibrosarcoma L929 cells. Basal levels of TNF production by mononuclear cells from 13 normal rabbits (124.3 units/ml ± 27.1 units/ml, mean ± SE) were not different from nine rabbits with colitis (83.6 units/ml ± 24.4 units/ml, P > 0.05). Treatment with lipopolysaccharide (100 μg/ml) induced increased TNF production by mononuclear cells isolated from both normals (672.0 units/ml ± 197.5 units/ml, P < 0.05) and rabbits with colitis (1114.0 units/ml ± 489.6 units/ml, P < 0.05). However, at all lipopolysaccharide concentrations stimulated TNF levels were comparable in experimental and control groups (P > 0.05). In light of the role of leukotrienes in inflammation, a separate group of rabbits with colitis was investigated following treatment with an oral leukotriene B4 receptor antagonist. Serum TNF levels in 15 control rabbits (32.5 units/ml ± 7.6 units/ml, mean ± SE) were not significantly different from rabbits with colitis receiving either leukotriene B4 receptor antagonist (35.7 units/ml ± 9.2 units/ml, N = 13) or vehicle alone (50.3 units/ml ± 10.2 units/ml, N = 14) (ANOVA, P > 0.05). These data indicate that systemic levels of TNF are not elevated in this experimental model of chronic colitis. Therefore, other inflammatory mediators with biological functions parallel to those of TNF are likely to mediate the systemic manifestations of colitis. |
Persistent Identifier | http://hdl.handle.net/10722/170252 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 1.068 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mack, DR | en_US |
dc.contributor.author | Lau, AS | en_US |
dc.contributor.author | Sherman, PM | en_US |
dc.date.accessioned | 2012-10-30T06:06:59Z | - |
dc.date.available | 2012-10-30T06:06:59Z | - |
dc.date.issued | 1992 | en_US |
dc.identifier.citation | Digestive Diseases And Sciences, 1992, v. 37 n. 11, p. 1738-1745 | en_US |
dc.identifier.issn | 0163-2116 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170252 | - |
dc.description.abstract | Tumor necrosis factor-alpha (TNF) is a cytokine released by mononuclear cells in response to inflammation and sepsis. Since the biological effects of TNF are consistent with the systemic and nal features of ulcerative colitis, the role of TNF was examined in a rabbit model of chronic colitis. Peripheral blood mononuclear cells were isolated, stimulated with lipopolysaccharide, and cultured supernatants assayed for TNF levels using a cytotoxic assay on mouse fibrosarcoma L929 cells. Basal levels of TNF production by mononuclear cells from 13 normal rabbits (124.3 units/ml ± 27.1 units/ml, mean ± SE) were not different from nine rabbits with colitis (83.6 units/ml ± 24.4 units/ml, P > 0.05). Treatment with lipopolysaccharide (100 μg/ml) induced increased TNF production by mononuclear cells isolated from both normals (672.0 units/ml ± 197.5 units/ml, P < 0.05) and rabbits with colitis (1114.0 units/ml ± 489.6 units/ml, P < 0.05). However, at all lipopolysaccharide concentrations stimulated TNF levels were comparable in experimental and control groups (P > 0.05). In light of the role of leukotrienes in inflammation, a separate group of rabbits with colitis was investigated following treatment with an oral leukotriene B4 receptor antagonist. Serum TNF levels in 15 control rabbits (32.5 units/ml ± 7.6 units/ml, mean ± SE) were not significantly different from rabbits with colitis receiving either leukotriene B4 receptor antagonist (35.7 units/ml ± 9.2 units/ml, N = 13) or vehicle alone (50.3 units/ml ± 10.2 units/ml, N = 14) (ANOVA, P > 0.05). These data indicate that systemic levels of TNF are not elevated in this experimental model of chronic colitis. Therefore, other inflammatory mediators with biological functions parallel to those of TNF are likely to mediate the systemic manifestations of colitis. | en_US |
dc.language | eng | en_US |
dc.publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0163-2116 | en_US |
dc.relation.ispartof | Digestive Diseases and Sciences | en_US |
dc.subject | colitis | - |
dc.subject | inflammatory bowel disease | - |
dc.subject | intestine | - |
dc.subject | leukotrienes | - |
dc.subject | tumor necrosis factor | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Benzopyrans - Administration & Dosage | en_US |
dc.subject.mesh | Cells, Cultured - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Colitis, Ulcerative - Blood - Chemically Induced - Drug Therapy | en_US |
dc.subject.mesh | Dinitrochlorobenzene | en_US |
dc.subject.mesh | Disease Models, Animal | en_US |
dc.subject.mesh | Escherichia Coli | en_US |
dc.subject.mesh | Leukocytes, Mononuclear - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Leukotriene B4 - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Lipopolysaccharides - Pharmacology | en_US |
dc.subject.mesh | Rabbits | en_US |
dc.subject.mesh | Receptors, Immunologic - Drug Effects | en_US |
dc.subject.mesh | Receptors, Leukotriene B4 | en_US |
dc.subject.mesh | Tumor Necrosis Factor-Alpha - Analysis - Biosynthesis - Drug Effects | en_US |
dc.title | Systemic tumor necrosis factor-alpha production in experimental colitis | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lau, AS:asylau@hku.hk | en_US |
dc.identifier.authority | Lau, AS=rp00474 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1007/BF01299868 | en_US |
dc.identifier.pmid | 1330461 | - |
dc.identifier.scopus | eid_2-s2.0-0026484749 | en_US |
dc.identifier.volume | 37 | en_US |
dc.identifier.issue | 11 | en_US |
dc.identifier.spage | 1738 | en_US |
dc.identifier.epage | 1745 | en_US |
dc.identifier.isi | WOS:A1992JY62400018 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Mack, DR=7102096227 | en_US |
dc.identifier.scopusauthorid | Lau, AS=7202626202 | en_US |
dc.identifier.scopusauthorid | Sherman, PM=7203008320 | en_US |
dc.identifier.issnl | 0163-2116 | - |